Company Filing History:
1 out of 5,089 
1 out of 43 
1 out of 42 
Years Active: 2017
Title: Remi Guillon: Innovator in Cancer Treatment
Introduction
Remi Guillon is a notable inventor based in Montpellier, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Guillon holds a patent for "5'-nucleotidase inhibitors and therapeutic uses thereof." This invention involves compounds with a 6-aminopurine backbone, which are designed for use in the treatment of cancer. The patent outlines specific structural formulas and therapeutic applications that could potentially enhance cancer treatment options.
Career Highlights
Throughout his career, Remi Guillon has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and Hospices Civils de Lyon. His work in these institutions has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Guillon has collaborated with notable colleagues, including Laurent Chaloin and Suzanne Peyrottes, who have contributed to his research endeavors.
Conclusion
Remi Guillon's innovative work in developing cancer treatment compounds highlights his commitment to advancing medical science. His contributions through patents and collaborations reflect his significant role in the field of cancer research.